Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1654 1658 1675
This examiner grants 50% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 16630271 | COMPOSITIONS AND METHODS FOR TREATING MYELIN DISORDERS | Non-Final OA | CASE WESTERN RESERVE UNIVERSITY |
| 18632978 | METHOD TO INHIBIT NEUTROPHIL RECRUITMENT TO DAMAGED TISSUE USING MYELOID-DERIVED GROWTH FACTOR | Non-Final OA | Wisconsin Alumni Research Foundation |
| 17291937 | 2,5-DIOXOPIPERAZINE LIPIDS WITH INTERCALATED ESTER, THIOESTER, DISULFIDE AND ANHYDRIDE MOIEITIES | Non-Final OA | Translate Bio, Inc. |
| 17362191 | METHODS OF PROPHYLACTIC TREATMENT USING RECOMBINANT VWF (rVWF) | Final Rejection | Takeda Pharmaceutical Company Limited |
| 15700693 | SEALANT FORMULATIONS AND USES THEREOF | Non-Final OA | Omrix Biopharmaceuticals Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy